Yukihito Kuroda

Tsukuba, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Enhancing Immunotherapeutic Response in Colorectal Cancer with a Neuropilin 1-Targeting Tumor-Penetrating Peptide.

Enhancing Immunotherapeutic Response in Colorectal Cancer with a Neuropilin 1-Targeting Tumor-Penetrating Peptide.

Journal: Cancer research communications
Published: October 10, 2025

Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer.

Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer.

Journal: Cancer research
Published: September 18, 2025

Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics.

Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics.

Journal: British journal of cancer
Published: June 05, 2025

Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer.

Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer.

Journal: Frontiers in cell and developmental biology
Published: October 25, 2023

Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations.

Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations.

Journal: Journal of oncology
Published: September 02, 2023

Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker.

Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker.

Journal: bioRxiv : the preprint server for biology
Published: June 09, 2023

Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: 18 F-labeled rBC2LCN lectin.

Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: 18 F-labeled rBC2LCN lectin.

Journal: Cancer science
Published: January 09, 2023

Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer.

Lectin-based phototherapy targeting cell surface glycans for pancreatic cancer.

Journal: International journal of cancer
Published: June 09, 2022

Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.

Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: December 01, 2021

Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin.

Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin.

Journal: European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes
Published: July 17, 2020

Lectin drug conjugate therapy for colorectal cancer.

Lectin drug conjugate therapy for colorectal cancer.

Journal: Cancer science
Published: July 02, 2020

A case of sigmoid colon perforation presenting with pneumomediastinum.

A case of sigmoid colon perforation presenting with pneumomediastinum.

Journal: Journal of surgical case reports
Published: August 15, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026